CRESPIATICO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 297
EU - Europa 140
AS - Asia 26
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 470
Nazione #
US - Stati Uniti d'America 285
IT - Italia 46
IE - Irlanda 18
FR - Francia 15
CN - Cina 13
DE - Germania 13
RU - Federazione Russa 11
CZ - Repubblica Ceca 10
CA - Canada 8
FI - Finlandia 8
NL - Olanda 5
UA - Ucraina 5
MX - Messico 4
GB - Regno Unito 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
EG - Egitto 2
IL - Israele 2
IN - India 2
JP - Giappone 2
RO - Romania 2
VN - Vietnam 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CL - Cile 1
GH - Ghana 1
ID - Indonesia 1
KR - Corea 1
SG - Singapore 1
SI - Slovenia 1
Totale 470
Città #
Fairfield 30
Houston 26
Seattle 25
Santa Cruz 24
Milan 23
Ashburn 20
Dublin 18
Los Angeles 16
Woodbridge 14
Cambridge 12
Buffalo 10
Columbus 10
Frankfurt am Main 9
Wilmington 8
Boardman 7
Shanghai 7
Monza 6
Helsinki 5
Ann Arbor 4
Chicago 4
Ottawa 4
Carate Brianza 3
Clearwater 3
Lappeenranta 3
Toronto 3
Ahi'ezer 2
Andover 2
Beijing 2
Cesena 2
Columbia 2
Corbetta 2
Dong Ket 2
Juprelle 2
Meda 2
Mexico 2
Muizenberg 2
Parsippany 2
Riva 2
Saint Petersburg 2
San Diego 2
San Francisco 2
Turin 2
Alexandria 1
Amsterdam 1
Bangalore 1
Bergamo 1
Blackheath 1
Brookfield 1
Cedar Knolls 1
Clifton 1
Dallas 1
Des Moines 1
Hangzhou 1
Henderson 1
Indiana 1
Jacksonville 1
Jakarta 1
Lake Forest 1
Las Vegas 1
Legnano 1
Lille 1
Ljubljana 1
Lombard 1
Miami 1
Nuremberg 1
Pasadena 1
Perugia 1
Phoenix 1
Portland 1
Provo 1
Rochester 1
Sacheon-si 1
San Jose 1
Scarsdale 1
Shenzhen 1
Tirana 1
Tong 1
University Park 1
Uruapan 1
Wuhan 1
Yekaterinburg 1
Zittau 1
Totale 368
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways, file e39773b6-139c-35a3-e053-3a05fe0aac26 174
An Imatinib–non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization, file e39773b6-422d-35a3-e053-3a05fe0aac26 111
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine, file e39773b7-0979-35a3-e053-3a05fe0aac26 101
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples, file 094f4414-1112-4ff5-96df-ed475a1bfd60 29
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients, file 9735d224-145c-43b6-bada-8dd6247afd5d 27
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis, file 60a40a1a-ab28-49e1-b4bc-bef3be2527e9 17
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis, file b5666ee7-44e0-40dd-bd1b-a5c9f0c00adc 12
Idiopathic erythrocytosis: a germline disease?, file 9c8c1c9f-8c8d-4f91-a1c2-311e6a64229b 7
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis, file 118763bb-674c-4c98-962d-7f8ddf14cd64 3
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models, file 473ea030-9297-4dc8-a1fb-d01126092e55 3
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis, file 82265667-eda8-482f-bd06-c774cc54d4a4 2
Long-term Results after Hyaluronan-based MACT for the Treatment of Cartilage Lesions of the Patellofemoral Joint, file e39773b5-ed7a-35a3-e053-3a05fe0aac26 1
Totale 487
Categoria #
all - tutte 1.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 3 5 5 6 11 6 2
2020/2021152 9 7 8 4 4 6 56 13 8 10 18 9
2021/202287 2 5 6 7 8 6 7 6 5 3 24 8
2022/202387 4 8 26 8 2 2 8 2 1 3 11 12
2023/2024123 5 5 8 12 5 24 18 20 6 9 11 0
Totale 487